Zevra Therapeutics, Inc. ZVRA
NASDAQ · United States · Health Technology
$10.62-0.35 (-3.16%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.14 | 0.11 | +27.3% | $39.66M | +17.1% | +12.9%$10.52→$11.88 |
| Q1 2026 | 2026-05-06 | 0.18 | 0.06 | +200.0% | — | — | +3.7% |
| Q4 2025 | 2026-03-09 | 0.19 | 0.05 | +280.0% | — | — | +23.2%$8.98→$11.06 |
| Q3 2025 | 2025-11-05 | -0.01 | -0.04 | +75.0% | — | — | -7.2%$9.79→$9.09 |
| Q2 2025 | 2025-08-12 | -0.06 | 1.38 | -104.3% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.06 | -0.18 | +66.7% | — | — | — |
| Q4 2024 | 2025-03-11 | -0.69 | -0.40 | -72.5% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.48 | -0.44 | -9.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.